See more : AMPAK Technology Inc. (6546.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of PharmaCom BioVet, Inc. (PHMB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PharmaCom BioVet, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Nexa Resources S.A. (NEXA.TO) Income Statement Analysis – Financial Results
- Aflac Incorporated (AFL) Income Statement Analysis – Financial Results
- Jaws Juggernaut Acquisition Corporation (JUGG) Income Statement Analysis – Financial Results
- Swiss Steel Holding AG (0QPH.L) Income Statement Analysis – Financial Results
- Bastide Le Confort Médical SA (BLC.PA) Income Statement Analysis – Financial Results
PharmaCom BioVet, Inc. (PHMB)
Industry: Medical - Care Facilities
Sector: Healthcare
About PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The company was formerly known as ABV Gold Inc. and changed its name to PharmaCom BioVet, Inc. in August 2008. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina.
Source: https://incomestatements.info
Category: Stock Reports